Position in BNTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,755,692
+$1,860,249 QoQ
Shares Held
51,109
+56.9% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#82
of 282 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026USS Investment Management Ltd holds $177,836,332 across 11 Biotechnology names. BNTX ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
57,903 | $53,720,666 | |
| 2 | ASND |
Ascendis Pharma A/S
|
141,010 | $37,610,187 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
48,893 | $24,286,619 | |
| 4 | INSM |
INSMED Inc
|
196,253 | $20,924,494 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
21,035 | $13,116,163 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
34,492 | $10,383,126 | |
| 7 | RPRX |
Royalty Pharma plc
|
136,346 | $7,644,920 | |
| 8 | BNTX |
BioNTech SE
This page
|
51,109 | $4,755,692 |
All Filings in BNTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,755,692 | 51,109 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,895,443 | 32,577 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $3,064,964 | 32,195 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,743,805 | 27,822 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,962,208 | 27,822 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,533,471 | 27,822 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,173,507 | 27,850 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||